annual EBIT:
-$179.93M-$110.53M(-159.27%)Summary
- As of today (September 16, 2025), OCUL annual earnings before interest & taxes is -$179.93 million, with the most recent change of -$110.53 million (-159.27%) on December 31, 2024.
- During the last 3 years, OCUL annual EBIT has fallen by -$180.05 million (-152582.20%).
- OCUL annual EBIT is now -152582.20% below its all-time high of $118.00 thousand, reached on December 31, 2021.
Performance
OCUL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$64.80M-$3.73M(-6.11%)Summary
- As of today (September 16, 2025), OCUL quarterly earnings before interest & taxes is -$64.80 million, with the most recent change of -$3.73 million (-6.11%) on June 30, 2025.
- Over the past year, OCUL quarterly EBIT has dropped by -$24.22 million (-59.68%).
- OCUL quarterly EBIT is now -1449.96% below its all-time high of $4.80 million, reached on March 31, 2021.
Performance
OCUL quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$204.42M-$24.22M(-13.44%)Summary
- As of today (September 16, 2025), OCUL TTM earnings before interest & taxes is -$204.42 million, with the most recent change of -$24.22 million (-13.44%) on June 30, 2025.
- Over the past year, OCUL TTM EBIT has dropped by -$80.88 million (-65.47%).
- OCUL TTM EBIT is now -171879.83% below its all-time high of $119.00 thousand, reached on December 31, 2021.
Performance
OCUL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
OCUL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -159.3% | -59.7% | -65.5% |
| 3 y3 years | -10000.0% | -279.6% | -692.8% |
| 5 y5 years | -124.2% | -85.8% | -112.7% |
OCUL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | -2326.7% | at low | -692.8% | at low |
| 5 y | 5-year | <-9999.0% | at low | -1450.0% | +22.8% | <-9999.0% | at low |
| alltime | all time | <-9999.0% | at low | -1450.0% | +22.8% | <-9999.0% | at low |
OCUL EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$64.80M(+6.1%) | -$204.42M(+13.4%) |
| Mar 2025 | - | -$61.07M(+34.9%) | -$180.20M(+0.2%) |
| Dec 2024 | -$179.93M(+159.3%) | -$45.28M(+36.1%) | -$179.93M(+12.7%) |
| Sep 2024 | - | -$33.27M(-18.0%) | -$159.72M(+29.3%) |
| Jun 2024 | - | -$40.58M(-33.3%) | -$123.54M(+21.5%) |
| Mar 2024 | - | -$60.80M(+142.5%) | -$101.65M(+46.5%) |
| Dec 2023 | -$69.40M(+8.4%) | -$25.07M(-961.5%) | -$69.40M(+19.6%) |
| Sep 2023 | - | $2.91M(-115.6%) | -$58.03M(-30.4%) |
| Jun 2023 | - | -$18.69M(-34.5%) | -$83.33M(+2.0%) |
| Mar 2023 | - | -$28.55M(+108.5%) | -$81.71M(+27.6%) |
| Dec 2022 | -$64.02M(<-9900.0%) | -$13.70M(-38.8%) | -$64.02M(+22.0%) |
| Sep 2022 | - | -$22.39M(+31.2%) | -$52.49M(+103.6%) |
| Jun 2022 | - | -$17.07M(+57.2%) | -$25.78M(+65.9%) |
| Mar 2022 | - | -$10.86M(+400.4%) | -$15.54M(<-9900.0%) |
| Dec 2021 | $118.00K(-100.1%) | -$2.17M(-150.3%) | $119.00K(-100.1%) |
| Sep 2021 | - | $4.32M(-163.2%) | -$81.60M(-15.1%) |
| Jun 2021 | - | -$6.83M(-242.2%) | -$96.14M(-22.6%) |
| Mar 2021 | - | $4.80M(-105.7%) | -$124.19M(-16.6%) |
| Dec 2020 | -$148.87M(+85.5%) | -$83.89M(+720.1%) | -$148.87M(+66.9%) |
| Sep 2020 | - | -$10.23M(-70.7%) | -$89.19M(-7.2%) |
| Jun 2020 | - | -$34.87M(+75.4%) | -$96.09M(+14.3%) |
| Mar 2020 | - | -$19.88M(-17.9%) | -$84.04M(+4.7%) |
| Dec 2019 | -$80.27M | -$24.21M(+41.4%) | -$80.27M(+9.8%) |
| Sep 2019 | - | -$17.13M(-25.0%) | -$73.08M(+3.6%) |
| Jun 2019 | - | -$22.83M(+41.7%) | -$70.54M(+15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$16.11M(-5.4%) | -$61.07M(+4.9%) |
| Dec 2018 | -$58.24M(-5.3%) | -$17.02M(+16.7%) | -$58.24M(+8.2%) |
| Sep 2018 | - | -$14.59M(+9.3%) | -$53.83M(-0.9%) |
| Jun 2018 | - | -$13.35M(+0.5%) | -$54.32M(-8.2%) |
| Mar 2018 | - | -$13.28M(+5.3%) | -$59.19M(-3.7%) |
| Dec 2017 | -$61.49M(+42.9%) | -$12.61M(-16.3%) | -$61.49M(+0.3%) |
| Sep 2017 | - | -$15.08M(-17.3%) | -$61.29M(+10.7%) |
| Jun 2017 | - | -$18.23M(+17.0%) | -$55.38M(+14.9%) |
| Mar 2017 | - | -$15.58M(+25.6%) | -$48.18M(+12.0%) |
| Dec 2016 | -$43.02M(+13.1%) | -$12.40M(+35.3%) | -$43.02M(+5.3%) |
| Sep 2016 | - | -$9.17M(-16.8%) | -$40.85M(-4.6%) |
| Jun 2016 | - | -$11.03M(+5.8%) | -$42.80M(+3.4%) |
| Mar 2016 | - | -$10.42M(+1.9%) | -$41.37M(+8.8%) |
| Dec 2015 | -$38.02M(+38.1%) | -$10.23M(-8.0%) | -$38.02M(+7.6%) |
| Sep 2015 | - | -$11.12M(+15.8%) | -$35.34M(+13.6%) |
| Jun 2015 | - | -$9.60M(+35.8%) | -$31.11M(+12.6%) |
| Mar 2015 | - | -$7.07M(-6.3%) | -$27.64M(+0.4%) |
| Dec 2014 | -$27.53M(+113.8%) | -$7.55M(+9.7%) | -$27.53M(+17.7%) |
| Sep 2014 | - | -$6.88M(+12.2%) | -$23.40M(+41.7%) |
| Jun 2014 | - | -$6.13M(-11.9%) | -$16.51M(+23.6%) |
| Mar 2014 | - | -$6.96M(+104.0%) | -$13.36M(+41.4%) |
| Dec 2013 | -$12.88M(-6.1%) | -$3.41M(+14.4%) | -$9.45M(+56.6%) |
| Jun 2013 | - | -$2.98M(-2.2%) | -$6.03M(+97.8%) |
| Mar 2013 | - | -$3.05M | -$3.05M |
| Dec 2012 | -$13.72M | - | - |
FAQ
- What is Ocular Therapeutix, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. annual EBIT year-on-year change?
- What is Ocular Therapeutix, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. quarterly EBIT year-on-year change?
- What is Ocular Therapeutix, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. TTM EBIT year-on-year change?
What is Ocular Therapeutix, Inc. annual earnings before interest & taxes?
The current annual EBIT of OCUL is -$179.93M
What is the all time high annual EBIT for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high annual earnings before interest & taxes is $118.00K
What is Ocular Therapeutix, Inc. annual EBIT year-on-year change?
Over the past year, OCUL annual earnings before interest & taxes has changed by -$110.53M (-159.27%)
What is Ocular Therapeutix, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of OCUL is -$64.80M
What is the all time high quarterly EBIT for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high quarterly earnings before interest & taxes is $4.80M
What is Ocular Therapeutix, Inc. quarterly EBIT year-on-year change?
Over the past year, OCUL quarterly earnings before interest & taxes has changed by -$24.22M (-59.68%)
What is Ocular Therapeutix, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of OCUL is -$204.42M
What is the all time high TTM EBIT for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high TTM earnings before interest & taxes is $119.00K
What is Ocular Therapeutix, Inc. TTM EBIT year-on-year change?
Over the past year, OCUL TTM earnings before interest & taxes has changed by -$80.88M (-65.47%)